Showing 1 - 5 results of 5 for search 'Conrad-Amadeus Voltin', query time: 0.03s
Refine Results
-
1
Influences on PET Quantification and Interpretation by Julian M. M. Rogasch, Frank Hofheinz, Lutz van Heek, Conrad-Amadeus Voltin, Ronald Boellaard, Carsten Kobe
Published 2022-02-01
Article -
2
Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD by Nadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, Carsten Kobe, Michael Hallek, Christof Scheid, Peter Borchmann, Udo Holtick
Published 2022-07-01
Article -
3
P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial by Lutz Van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz, Christian Baues, Michael Fuchs, Peter Borchmann, Andreas Engert, Markus Dietlein, Conrad-Amadeus Voltin, Carsten Kobe
Published 2022-10-01
Article -
4
P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma by Conrad-Amadeus Voltin, Stefanie Kreissl, Helen Kaul, Ina Bühnen, Jasmin Mettler, Thomas Pabst, Dennis A. Eichenauer, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann, Carsten Kobe
Published 2022-10-01
Article -
5
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy by Conrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, Markus Dietlein, Ken Herrmann, Matthias Stelljes, Kambiz Rahbar, Georg Lenz, H. Christian Reinhardt, Marcel Teichert, Richard Noppeney, Jörn C. Albring, Robert Seifert, Bastian von Tresckow, Sarah Flossdorf, Christine Hanoun
Published 2023-01-01
Article